Pharmacy Technician Training and Registration Act of 2008

See addendum. H.R.970, the Dextromethorphan Distribution Act, as related to the abuse of dextromethorphan. H.R.971, the Community Pharmacy Fairness Act, as related to provider negotiations in the Medicare program. H.R.1038/S.623, Access to Life-Saving Medicine Act, as related to the approval of generic biopharmaceuticals. H.R.1108, Family Smoking Prevention and Tobacco Control Act, as related to the regulation of the sale of tobacco products. H.R.1474, the Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act, as related to provider reimbursement in the Medicare program. H.R.3140, Saving Our Community Pharmacies Act, as related to Medicaid provider reimbursement. H.R.3193, Access to Community Pharmacy Preservation Act, as related to Medicaid provider reimbursement. H.R.3700, the Fair Medicaid Drug Payment Act, as related to pharmacy reimbursement in the Medicaid program. H.R.4008, Credit and Debit Card Receipt Clarification Act of 2007, as related to fair credit card practices. H.R.5491, Emilys Act, as related to the certification of pharmacy technicians. H.R.5546, Credit Card Fair Fee Act of 2008, as related to fair credit card practices. H.R.5613, Protecting the Medicaid Safety Net Act of 2008, as related to provider participation in the Medicaid program. H.R.5629, Pathway for Biosimilars Act, as related to the availability of generic pharmaceuticals. H.R.5658, Duncan Hunter National Defense Authorization Act for Fiscal Year 2009, as related to provider participation in the TRICARE program. H.R.5839, Safeguarding America's Pharmaceuticals Act of 2008, as related to drug safety and electronic tracking of pharmaceuticals. H.R.6252, Medicare DMEPOS Competitive Acquisition Reform Act of 2008, as related to provider participation in the Medicare competitive bidding program. H.R.6331, the Medicare Improvements for Patients and Providers Act of 2008, as related to pharmacy reimbursement, electronic health care, and Medicare programs. H.R.6353, Ryan Haight Online Pharmacy Consumer Protection Act of 2008, as related to online pharmacies. H.R.6357, PRO(TECH)T Act of 2008, as related to health information technology. S.484, the Enhancing Drug Safety and Innovation Act, all provisions related to the safety of prescription medicines. S.980, Ryan Haight Online Pharmacy Consumer Protection Act of 2008, as related to online pharmacies. S.1693, Wired for Health Care Quality Act, as related to health information technology. S.1695, the Biologics Price Competition and Innovation Act, as related to the approval of generic biopharmaceuticals. S.1827, Pharmacists Access and Recognition in Medicare (PhARM) Act, as related to provider participation in the Medicare program. S.1915, Electronic Prescribing Drug Act, as related to the regulation of electronic prescribing of pharmaceuticals. S.1951, the Fair Medicaid Drug Payment Act, as related to pharmacy reimbursement in the Medicaid program. S.1954, Pharmacy Access Improvement (PhAIm) Act, as related to access standards to pharmacies. S.2013/H.R.390, Patient and Pharmacy Protection Act, as related to prescription requirements in the Medicaid program. S.2071, Combat Methamphetamine Enhancement Act, as related to the distributio of legal substances used in the production of methamphetamine. S.2274, Dextromethorphan Abuse Reduction Act, as related to the abuse of dextromethorphan. S.2408/H.R.4296, Medicare Electronic Medication and Safety Protection (E-MEDS) Act of 2007, as related to electronic health care in the Medicare program. S.2978, Credit and Debit Card Receipt Clarification Act of 2008, as related to fair credit card practices S.3001, National Defense Authorization Act for Fiscal Year 2009, as related to provider participation in the TRICARE program. S.3086, Credit Card Fair Fee Act of 2008, as related to fair credit card practices. S.3101, Medicare Improvements for Patients and Providers Act of 2008, as related to pharmacy reimbursement and electronic health care.

Client expense: $420,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Drug Enforcement Administration (DEA), Executive Office of the President (EOP), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Office of Natl Drug Control Policy (NDCP), President of the U.S., SENATE

S. 1951/H.R. 3700 the "Fair Medicaid Drug Payment Act of 2007" - Medicaid reimbursement for generic drugs as related to average manufacturer's price (AMP) and federal upper limits (FULs); H.R. 3140 "Saving Our Community Pharmacies Act of 2007" - Medicaid reimbursement for generic drugs as related to AMP and FULs; S. 980 the "Online Pharmacy Consumer Protection Act of 2007" - regarding amendments to the control substances act relating to the delivery of control substances over the internet; S. 2408 the "E-Meds Act of 2007" - e-prescribing in Medicare - regarding amendments to the Social Security Act requiring physicians to utilize electronic prescribing for Medicare prescriptions; H.R. 3580 the 'Food and Drug Administration Amendments Act of 2007" - Sec 505d regarding pharmaceutical safety and anti-counterfeiting; S. 1082 the "FDA Revitalization Act of 2007" -Sec. 514 regarding anti-counterfeiting technology, Sec. 807 internet pharmacy, MedGuides for prescription drugs; H.R. 2900 the "Food and Drug Amendments Act of 2007" - Sec. 910 regarding pharmaceutical safety, MedGuides for prescription drugs; H.R.5491 the "Pharmacy Technician Training and Registration Act of 2008 regarding grant programs to allow states to establish and implement technician registration programs; H.R. 5629 the "Pathway to Biosimilars Act" regarding licensure pathway for biogenerics; H.R. 1956 the "Patient Protection and Innovative Biologic Medicines Act of 2007" regarding amending the Public Health Service Act to provide for approval of biosimilar products; S. 1145 the "Patent Reform Act of 2007" Sec 12 regarding inequitable conduct and the development of a pathway for approval of biogenerics; Electronic Prescribing of Controlled Substances - regarding the need for the DEA to publish rules that would allow for electronic prescribing of controlled substances - no specific legislation; TRICARE pharmacy program as it relates to Federal Supply Schedule pricing for drugs dispensed in retail pharmacies and the copays at retail pharmacy - no specific legislation

See addendum. 1.S.242/H.R.380, the Pharmaceutical Market Access and Drug Safety Act of 2007, as related to provisions governing the importation of prescription drugs. 2.S.251, the Pharmaceutical Market Access Act of 2007, all provisions governing the importation of prescription drugs. 3.S. 484, the Enhancing Drug Safety and Innovation Act of 2007, all provisions related to the safety of prescription medicines. 4.S. 604, the Military Health Care Protection Act, as related to provider participation in the Department of Defense TRICARE program. 5.S. 980, Online Pharmacy Consumer Protection Act of 2007, as related to the regulation of online pharmacies. 6.S. 1200, Indian Health Care Improvement Act Amendments of 2007, all provisions related to reducing fraud and abuse in the Medicare program. 7.S. 1276/H.R.2747, the Methamphetamine Production Prevention Act of 2007, as related to the distribution of legal substances used in the production of methamphetamine. 8.S. 1693, the Wired for Health Care Quality Act of 2007, as related to improving health information technology. 9.S. 1695, the Biologics Price Competition and Innovation Act of 2007, as related to the approval of generic biopharmaceuticals. 10.S. 1827, Pharmacist Access and Recognition in Medicare (PhARM) Act of 2007 as related to provider participation in the Medicare program. 11.S.1915, Electronic Prescription Drug Act of 2007, as related to the regulation of electronic prescribing of pharmaceuticals 12.S.1951/H.R.3700, Fair Medicaid Drug Payment Act of 2007, as related to Medicaid provider reimbursement. 13.S.1954, Pharmacy Access Improvement (PhAIm) Act of 2007, as related to access standards to pharmacies. 14.S.2013/H.R.3090, Patient and Pharmacy Protection Act of 2007, as related to prescription requirements in the Medicaid program. 15.S.2071, Combat Methamphetamine Enhancement Act of 2007, as related to the distribution of legal substances used in the production of methamphetamine. 16.S.2274, Dextromethorphan Abuse Reduction Act of 2007, as related to steps to prevent the abuse of dextromethorphan. 17.S.2408/H.R.4296, Medicare Electronic Medication and Safety Protection (E-MEDS) Act of 2007, as related to the regulation of electronic prescribing of pharmaceuticals. 18.H.R.976, Small Business Tax Relief Act of 2007, all provisions associated with work-related tax credits. 19.H.R. 970, the Dextromethorphan Distribution Act of 2007, as related to steps to prevent the abuse of dextromethorphan. 20.H.R. 971/S.855, the Community Pharmacy Fairness Act of 2007, as related to provider negotiations in the Medicare program. 21.H.R.1038/S.623, Access to Life-Saving Medicine Act, as related to the approval of generic biopharmaceuticals. 22.H.R. 1474, the Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007, as related to provider reimbursement in the Medicare program 23.H.R.1585/S.1548, National Defense Authorization Act for Fiscal Year 2008, as related to retail pharmacy participation in the Department of Defense TRICARE program. 24.H.R.1845, the Medicare Durable Medical Equipment Access Act of 2007, as related to provider inclusion in the Medicare Part B program. 25.H.R.1902, the Protecting Consumer Access to Generic Drugs Act of 2007, as related to the availability of generic pharmaceuticals. 26.H.R.2716, the Reducing Fraudulent and Imitation Drugs Act of 2007, as related to the safety of prescription drugs. 27.H.R. 2900, the Food and Drug Administration Amendments of 2007, all provisions related to prescription drug information and safety. 28.H.R.3109, the Dental Health Promotion Act of 2007, all provisions related to payment for health services. 29.H.R.3140, Saving Our Community Pharmacies Act of 2007, as related to Medicaid provider reimbursement. 30.H.R.3162, Children's Health and Medicare Protection Act of 2007, provisions related to health insurance in the Medicare program. 31.H.R.3193, Access to Community Pharmacy Preservation Act of 2007, as related to Medicaid provider reimbursement. 32.H.R.3580, Food and Drug Administration Amendments Act of 2007, all provisions related to prescription drug information and safety. 33.H.R.3610, Food and Drug Import Safety Act of 2007, provisions related to the safety of prescription drugs. 34.H.R.5268/S.2620, Temporary Increase of Medicaid FMAP, all provisions related to payments in the Medicaid program. 35.H.R.5480/S.2662, Medicare Funding Warning Response Act of 2008, all provisions related to provider access and payments in the Medicare program. 36.H.R.5491, Emilys Act, as related to the certification of pharmacy technicians. 37.H.R.5546, Credit Card Fair Fee Act of 2008, as related to fees associated with credit card purchase. 38.H.R.5613, Protecting the Medicaid Safety Net Act of 2008, all provisions related to provider participation in the Medicaid program. 39.H.R.5629, Pathway for Biosimilars Act, as related to the availability of generic pharmaceuticals. 40.H.Con.Res.312/S.Con.Res.70, Concurrent Resolution on the Budget for Fiscal Year 2009, all provisions related to healthcare providers and prescription drugs.

Health Services and Resources Administration 340 B drug pricing program; proposed guidance on definition of patient, contract pharmacy and participation by children's hospitals. HR 3580, Food and Drug Administration Amendments Act of 2007, titles 8 and 9, all provisins. S.901. Reauthorization of National Health Service Corps. Provisions relating to loan forgiveness programs. Funding for Food and Drug Administration. HR 1956, Patient Protection and Innovative Biologic Medicines Act of 2007 and HR 1038, Access to Life Saving Medicine Act, HR 5629, Pathway for Biosimilars Act, provisions dealing with interchangability. HR 5491, Pharmacy Technician Training and Registration Act of 2008, all provisions. Proposal by FDA for a behind the counter drug category (public meeting and comments). Distribution of patient information and medication guides. Pharmacologic class in patient information. Proposal to transition Mevacor from prescription to over the counter status.

Client expense: $200,276 · Firm income: Not reported